Efficacy News and Research

RSS
Abbott announces results from HUMIRA clinical studies on ulcerative colitis

Abbott announces results from HUMIRA clinical studies on ulcerative colitis

Possible overlap exists between inflammatory bowel disease and IBS

Possible overlap exists between inflammatory bowel disease and IBS

Primary care physicians miss hepatitis vaccine targets

Primary care physicians miss hepatitis vaccine targets

PLoS ONE publishes review of AntiViral-HyperActivation Limiting Therapeutics clinical trial

PLoS ONE publishes review of AntiViral-HyperActivation Limiting Therapeutics clinical trial

Intensive glycemic control does not reduce mortality in neurocritical care patients

Intensive glycemic control does not reduce mortality in neurocritical care patients

Pediatric ICU patients often receive off-label drug treatments

Pediatric ICU patients often receive off-label drug treatments

Mistakes are still commonly made in prescriptions of antiretroviral medications

Mistakes are still commonly made in prescriptions of antiretroviral medications

Clinical trial to study immunosuppressant tacrolimus against generics

Clinical trial to study immunosuppressant tacrolimus against generics

Brain Injury Research Center of Mount Sinai receives fund to research on TBI

Brain Injury Research Center of Mount Sinai receives fund to research on TBI

Study describes design and effectiveness of NIR responsive gold nanorods for chemotherapy

Study describes design and effectiveness of NIR responsive gold nanorods for chemotherapy

EMA CHMP issues positive opinion to Savient's KRYSTEXXA for treatment of chronic gout

EMA CHMP issues positive opinion to Savient's KRYSTEXXA for treatment of chronic gout

ACT TIL therapy effective in treating metastatic melanoma

ACT TIL therapy effective in treating metastatic melanoma

Link between norovirus outbreaks and excess hospitalization and mortality in nursing homes

Link between norovirus outbreaks and excess hospitalization and mortality in nursing homes

Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive disorder

Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive disorder

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Genetic clues for responders to heart failure drug identified

Genetic clues for responders to heart failure drug identified

Ciclosporin no more effective than infliximab in severe UC

Ciclosporin no more effective than infliximab in severe UC

Value of cranberries for UTI prevention called into question

Value of cranberries for UTI prevention called into question

EMR before radiofrequency ablation safe and effective for patients with nodular Barrett's esophagus

EMR before radiofrequency ablation safe and effective for patients with nodular Barrett's esophagus

FDA accepts A.P. Pharma’s resubmission of NDA for APF530

FDA accepts A.P. Pharma’s resubmission of NDA for APF530

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.